222 related articles for article (PubMed ID: 27125991)
1. Accidental intralenticular dexamethasone intravitreal implant with the resolution of macular oedema in central retinal vein occlusion.
Abdolrahimzadeh S; Plateroti P; Scarinci F; Plateroti AM
Acta Ophthalmol; 2016 Dec; 94(8):e810-e811. PubMed ID: 27125991
[No Abstract] [Full Text] [Related]
2. Macular hole after injection of dexamethasone intravitreal implant for macular oedema due to central retinal vein occlusion.
De Benedetto U; Battaglia Parodi M; Knutsson KA; Lattanzio R; Bandello F; Iacono P
Acta Ophthalmol; 2013 Feb; 91(1):e75-7. PubMed ID: 22863290
[No Abstract] [Full Text] [Related]
3. Accidental injection of dexamethasone intravitreal implant in the crystalline lens.
Fasce F; Battaglia Parodi M; Knutsson KA; Spinelli A; Mauceri P; Bolognesi G; Bandello F
Acta Ophthalmol; 2014 Jun; 92(4):e330-1. PubMed ID: 24373603
[No Abstract] [Full Text] [Related]
4. Accidental injections of dexamethasone intravitreal implant (Ozurdex) into the crystalline lens.
Coca-Robinot J; Casco-Silva B; Armadá-Maresca F; García-Martínez J
Eur J Ophthalmol; 2014; 24(4):633-6. PubMed ID: 24519506
[TBL] [Abstract][Full Text] [Related]
5. OBSERVED COMPLICATIONS FROM DEXAMETHASONE INTRAVITREAL IMPLANT FOR THE TREATMENT OF MACULAR EDEMA IN RETINAL VEIN OCCLUSION OVER 3 TREATMENT ROUNDS.
Reid GA; Sahota DS; Sarhan M
Retina; 2015 Aug; 35(8):1647-55. PubMed ID: 25932545
[TBL] [Abstract][Full Text] [Related]
6. Comparison of intravitreal bevacizumab upload followed by a dexamethasone implant versus dexamethasone implant monotherapy for retinal vein occlusion with macular edema.
Mayer WJ; Remy M; Wolf A; Kook D; Kampik A; Ulbig M; Reznicek L; Haritoglou C
Ophthalmologica; 2012; 228(2):110-6. PubMed ID: 22739239
[TBL] [Abstract][Full Text] [Related]
7. Extramacular Retinal Hole Following Intravitreal Dexamethasone Implant: Case Report.
Ekinci C; Kayıran A; Özdemir H
Turk J Ophthalmol; 2019 Jun; 49(3):175-177. PubMed ID: 31245982
[TBL] [Abstract][Full Text] [Related]
8. The efficacy and safety of intravitreal dexamethasone implants for macular oedema secondary to retinal vein occlusion: 3-year experience.
Higham A; Jacob S; Cox M; Baker C; Al-Husainy S; Sivaraj R; Gibson JM
Acta Ophthalmol; 2016 Nov; 94(7):e674-e675. PubMed ID: 27010078
[No Abstract] [Full Text] [Related]
9. Intracrystalline Ozurdex
Clemente-Tomás R; Hernández-Pérez D; Neira-Ibáñez P; Farías-Rozas F; Torrecillas-Picazo R; Osorio-Alayo V; Duch-Samper AM
Int Ophthalmol; 2019 Jan; 39(1):207-211. PubMed ID: 29192395
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and Safety of Dexamethasone Intravitreal Implant for Treatment of Refractory Macular Edema Secondary to Retinal Vein Occlusion in Taiwan.
Sheu SJ; Wu TT; Horng YH
J Ocul Pharmacol Ther; 2015 Oct; 31(8):461-7. PubMed ID: 26067779
[TBL] [Abstract][Full Text] [Related]
11. Safety of 6000 intravitreal dexamethasone implants.
Rajesh B; Zarranz-Ventura J; Fung AT; Busch C; Sahoo NK; Rodriguez-Valdes PJ; Sarao V; Mishra SK; Saatci AO; Udaondo Mirete P; Querques G; Farah ME; Lanzetta P; Arevalo JF; Kodjikian L; Chhablani J;
Br J Ophthalmol; 2020 Jan; 104(1):39-46. PubMed ID: 31040132
[TBL] [Abstract][Full Text] [Related]
12. Intravitreal dexamethasone implant for the treatment of macular edema after retinal vein occlusion in a clinical setting.
Ferrini W; Ambresin A
Klin Monbl Augenheilkd; 2013 Apr; 230(4):423-6. PubMed ID: 23629796
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of two or more dexamethasone intravitreal implant injections for treatment of macular edema related to retinal vein occlusion (Shasta study).
Capone A; Singer MA; Dodwell DG; Dreyer RF; Oh KT; Roth DB; Walt JG; Scott LC; Hollander DA
Retina; 2014 Feb; 34(2):342-51. PubMed ID: 23846381
[TBL] [Abstract][Full Text] [Related]
14. Compassionate use of dexamethasone implant for the treatment of macular edema secondary to central retinal vein occlusion in a clinical setting.
Parodi MB; Iacono P; Cascavilla M; Zucchiatti I; Bandello F
Acta Ophthalmol; 2012 Jun; 90(4):e322-3. PubMed ID: 21939501
[No Abstract] [Full Text] [Related]
15. Does Intravitreal Dexamethasone Implant Fragmentation Affect Clinical Outcomes in Macular Edema from Branch Retinal Vein Occlusion?
Im JC; Shin JP; Kim IT; Park DH
Ophthalmologica; 2016; 236(2):74-80. PubMed ID: 27318489
[TBL] [Abstract][Full Text] [Related]
16. Evolution of vitreomacular traction following the use of the dexamethasone intravitreal implant (Ozurdex) in the treatment of macular edema secondary to central retinal vein occlusion.
Bakri SJ; Omar AF
J Ocul Pharmacol Ther; 2012 Oct; 28(5):547-9. PubMed ID: 22537269
[TBL] [Abstract][Full Text] [Related]
17. Sequential therapy with ranibizumab and dexamethasone intravitreal implant is better than dexamethasone monotherapy for macular oedema due to retinal vein occlusion.
Iu LP; Zhao P; Yeung IY; Fung NS; Lee JW; Wong RL; Chong V; Wong IY
Br J Ophthalmol; 2015 Feb; 99(2):210-4. PubMed ID: 25138756
[TBL] [Abstract][Full Text] [Related]
18. RETINA.
Retina; 2018 Jun; 38 Suppl 3():1-13. PubMed ID: 29889714
[No Abstract] [Full Text] [Related]
19. Inadvertent dexamethasone implant injection into the lens body management.
Berarducci A; Sian IS; Ling R
Eur J Ophthalmol; 2014; 24(4):620-2. PubMed ID: 24519508
[TBL] [Abstract][Full Text] [Related]
20. [Subconjunctival Ozurdex
Sampo M; Nadeau S; Denis D; Matonti F
J Fr Ophtalmol; 2019 Jan; 42(1):89-91. PubMed ID: 30594421
[No Abstract] [Full Text] [Related]
[Next] [New Search]
